Literature DB >> 31596171

HIV Pre-exposure Prophylaxis for People Who Inject Drugs: The Context of Co-occurring Injection- and Sexual-Related HIV Risk in the U.S. Northeast.

Alberto Edeza1,2, Angela Bazzi3, Peter Salhaney1,2, Dea Biancarelli4,5, Ellen Childs4, Matthew J Mimiaga1,2,6,7,8, Mari-Lynn Drainoni4,5,9,10, Katie Biello1,2,6,8.   

Abstract

Background: People who inject drugs (PWID) are at increased risk for HIV infection through sharing contaminated needles and injection equipment, and engaging in condomless sex.
Objectives: To qualitatively examine the overlapping nature of these behaviors among PWID in the US Northeast.
Methods: We recruited HIV-uninfected PWID and key informants through community-based organizations. Qualitative interviews explored sexual partnerships as they related to sharing contaminated needles and injection equipment, engaging in condomless sex, and associated indications for PrEP among PWID.
Results: Among 33 PWID, 66% engaged in condomless vaginal or anal sex in the past 3 months, and 27% had three or more sexual partners in this same time period. Over half engaged in any past month distributive or receptive syringe sharing (64%). We identified three contexts through which overlapping sexual and injection-related HIV risks emerged, including (1) multiple concurrent sexual partnerships; (2) using and injecting drugs with sexual partners (including increase injecting of crystal methamphetamine); and (3) exchanging sex for money or drugs (including among male PWID). Condom use was inconsistent across these contexts. Limited interactions with healthcare providers often resulted in sexual risks being overlooked in light of competing health concerns. Conclusions: Sexual risk for HIV acquisition is complex and multi-faceted among PWID yet may be overlooked by prevention and healthcare providers. Comprehensive HIV prevention efforts must acknowledge the distinct contexts in which overlapping injection and sexual risk behaviors occur. Increased sexual health screening and risk reduction services including PrEP for PWID may help curtail transmission in this population.

Entities:  

Keywords:  Condoms; HIV; Injection Drug Use; Sexual Behavior; Sexual Partners

Mesh:

Year:  2019        PMID: 31596171      PMCID: PMC7028455          DOI: 10.1080/10826084.2019.1673419

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  37 in total

1.  Syringe Service Programs for Persons Who Inject Drugs in Urban, Suburban, and Rural Areas - United States, 2013.

Authors:  Don C Des Jarlais; Ann Nugent; Alisa Solberg; Jonathan Feelemyer; Jonathan Mermin; Deborah Holtzman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-12-11       Impact factor: 17.586

2.  'PrEP is not ready for our community, and our community is not ready for PrEP': pre-exposure prophylaxis for HIV for people who inject drugs and limits to the HIV prevention response.

Authors:  Andy Guise; Eliot Ross Albers; Steffanie A Strathdee
Journal:  Addiction       Date:  2016-06-08       Impact factor: 6.526

3.  Predictors of HIV sexual risk behaviors in a community sample of injection drug-using men and women.

Authors:  Anton M Somlai; Jeffrey A Kelly; Timothy L McAuliffe; Kate Ksobiech; Kristin L Hackl
Journal:  AIDS Behav       Date:  2003-12

4.  Correlates of Sexual Coercion among People Who Inject Drugs (PWID) in Los Angeles and San Francisco, CA.

Authors:  Jeffery E Williams; Derek T Dangerfield; Alex H Kral; Lynn D Wenger; Ricky N Bluthenthal
Journal:  J Urban Health       Date:  2019-06       Impact factor: 3.671

5.  Men who have sex with men and also inject drugs-profiles of risk related to the synergy of sex and drug injection behaviors.

Authors:  Sheana Salyers Bull; Patrick Piper; Cornelis Rietmeijer
Journal:  J Homosex       Date:  2002

6.  HIV infection and HIV-associated behaviors among persons who inject drugs--20 cities, United States, 2012.

Authors:  Michael W Spiller; Dita Broz; Cyprian Wejnert; Lina Nerlander; Gabriela Paz-Bailey
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-03-20       Impact factor: 17.586

Review 7.  HIV pre-exposure prophylaxis for people who inject drugs: a review of current results and an agenda for future research.

Authors:  Daniel J Escudero; Mark N Lurie; Thomas Kerr; Chanelle J Howe; Brandon D L Marshall
Journal:  J Int AIDS Soc       Date:  2014-03-27       Impact factor: 5.396

8.  Estimating the number of persons who inject drugs in the united states by meta-analysis to calculate national rates of HIV and hepatitis C virus infections.

Authors:  Amy Lansky; Teresa Finlayson; Christopher Johnson; Deborah Holtzman; Cyprian Wejnert; Andrew Mitsch; Deborah Gust; Robert Chen; Yuko Mizuno; Nicole Crepaz
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

9.  Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.

Authors:  K B Biello; A R Bazzi; M J Mimiaga; D L Biancarelli; A Edeza; P Salhaney; E Childs; M L Drainoni
Journal:  Harm Reduct J       Date:  2018-11-12

10.  Factors Associated with Sexual Risks and Risk of STIs, HIV and Other Blood-Borne Viruses Among Women Using Heroin and Other Drugs: A Systematic Literature Review.

Authors:  L Medina-Perucha; H Family; J Scott; S Chapman; C Dack
Journal:  AIDS Behav       Date:  2019-01
View more
  5 in total

1.  Long-Acting Injectable Human Immunodeficiency Virus Pre-Exposure Prophylaxis Preferred Over Other Modalities Among People Who Inject Drugs: Findings from a Qualitative Study in California.

Authors:  Angela R Bazzi; Chad J Valasek; Samantha A Streuli; Carlos F Vera; Alicia Harvey-Vera; Morgan M Philbin; Katie B Biello; Alexis M Roth; Steffanie A Strathdee; Heather A Pines
Journal:  AIDS Patient Care STDS       Date:  2022-06-21       Impact factor: 5.944

2.  An Experimental Study of the Effects of Patient Race, Sexual Orientation, and Injection Drug Use on Providers' PrEP-Related Clinical Judgments.

Authors:  Sarah K Calabrese; David A Kalwicz; Djordje Modrakovic; Valerie A Earnshaw; E Jennifer Edelman; Samuel R Bunting; Ana María Del Río-González; Manya Magnus; Kenneth H Mayer; Nathan B Hansen; Trace S Kershaw; Joshua G Rosenberger; Douglas S Krakower; John F Dovidio
Journal:  AIDS Behav       Date:  2021-11-09

Review 3.  The Past, Present, and Future of PrEP implementation Among People Who Use Drugs.

Authors:  Katie B Biello; Matthew J Mimiaga; Pablo K Valente; Nimish Saxena; Angela R Bazzi
Journal:  Curr HIV/AIDS Rep       Date:  2021-04-27       Impact factor: 5.495

4.  High Prevalence of Indications for Pre-exposure Prophylaxis Among People Who Inject Drugs in Boston, Massachusetts.

Authors:  Joel J Earlywine; Angela R Bazzi; Katie B Biello; R Monina Klevens
Journal:  Am J Prev Med       Date:  2020-11-21       Impact factor: 5.043

5.  Reduction in injection risk behaviors after implementation of a syringe services program, Miami, Florida.

Authors:  Tyler S Bartholomew; Daniel J Feaster; Hardik Patel; David W Forrest; Hansel E Tookes
Journal:  J Subst Abuse Treat       Date:  2021-03-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.